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Background: Self-reported depressive symptoms and clinical depression after myocardial infarction (MI) are
both associated with poor cardiac prognosis. It is important to distinguish between the two when assessing
cardiac prognosis, but few studies have done so. The present article evaluates the independent prognostic im-
pact of self-reported depressive symptoms and clinical depression on cardiac outcomes after MI.
Methods: 2704 MI-patients were administered the Beck Depression Inventory (BDI) and underwent the Com-
posite International Diagnostic Interview at 3 months post-MI. All-cause mortality, cardiac mortality and car-
diovascular readmissions were evaluated up till 10 years post-MI (mean: 6 years), representing 16,783
persons-years of follow-up. Event-free survival was evaluated using Cox regression analysis.
Results: Analyses on mortality and cardiovascular readmissions included 2493 and 2434 patients respectively.
Compared to patients scoring b5 on the BDI, those scoring ≥19 had age- and sex-adjusted HR's (95% CI) of
3.20 (2.16–4.74, pb0.001) for all-cause mortality, 3.97 (2.06–7.65, pb0.001) for cardiac mortality, and 1.45
(1.08–1.95, pb0.05) for cardiovascular readmissions. Cardiac disease severity and cardiac risk factors
explained one third to half of the relationship. The presence of clinical depression was associated with
all-cause (HR: 1.72 (1.29–2.30, pb0.001)) and cardiac mortality (HR: 1.67 (1.01–2.77, pb0.05)). However,
adjusting for BDI-scores decreased these HR's with 53% and 72% respectively, rendering them non-signiﬁcant.
Dichotomized BDI-scores remained to predict cardiac prognosis independently from the presence of clinical
depression.
Conclusions: After MI, self-reported depressive symptoms are a more accurate predictor of cardiac morbidity
and mortality than clinical depression. This association is confounded largely by cardiac disease severity.© 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Depression after myocardial infarction (MI) is associated with
cardiovascular morbidity and mortality [1,2], but the association is
still poorly understood.
A largely understudied problem of studies in this ﬁeld is the
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50interviews or self-report questionnaires [3]. A diagnostic interview
evaluates the presence of symptoms of depression that make up a diag-
nosis of clinical depression according to the diagnostic statistic manual
(DSM) [4] or international classiﬁcation of diseases (ICD) [5]. To be in-
cluded, at least 5 symptoms must be present for at least 2 weeks.
These symptomsmust affect daily functioning and may not be a conse-
quence of a physiological problem. In contrast, a questionnaire evalu-
ates the current presence and severity of depressive symptoms which
do not necessarily correspond to the DSM symptoms of depression.
Because of these differences between the two types of depression
measurement, it is important to distinguish between self-reported
depressive symptoms and a diagnosis of clinical depression when ex-
amining their prognostic impact on cardiac outcomes. If depressive
symptoms and clinical depression indeed have a different prognostic
impact, this could have consequences for the comparability of previ-
ous studies, the design of future studies and clinical trials, and for
the identiﬁcation of high-risk patients in medical care settings.
Two studies found self-reported depressive symptoms to be more
strongly associated with adverse cardiac outcomes than clinical
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other studies found clinical depression to be more strongly associated
with adverse cardiac outcomes than self-reported depressive symp-
toms [8,9]. However, to date no study assessed whether the effects
of a diagnosis of clinical depression and self-reported depressive
symptoms on cardiac prognosis are independent of each other. There-
fore, this study evaluates the independent impact of a diagnosis of
clinical depression and self-reported depressive symptoms on new
cardiac events and mortality during an average follow-up of 6 years
after the MI in the largest sample of MI patients to date.
2. Materials and methods
2.1. Patients
Patients were included from the Depression after Myocardial Infarction (DepreMI)
study and the Myocardial Infarction and Depression Intervention Trial (MIND-IT).
DepreMI is a naturalistic cohort study evaluating the effects of post-MI depression on
cardiovascular prognosis, including 528 MI patients recruited consecutively from four
hospitals between September 1997 and September 2000. MIND-IT included 2176 MI
patients, recruited consecutively from 10 hospitals between September 1999 and
November 2002. Of the 2176 patients from MIND-IT, 331 depressed patients were ran-
domized to evaluate the effects of antidepressant treatment compared to usual care.
Details of these studies have been described before [10–12]. Eligible patients met at
least two of the following criteria: 1) chest pain for at least 20 min, 2) typical electro-
cardiographic changes, and 3) a documented increase in cardiac enzyme levels. Exclu-
sion criteria were another somatic disease likely to inﬂuence short-term survival, being
unable to participate in study procedures (e.g. were unable to communicate or not
available for follow-up), and already receiving antidepressant treatment (MIND-IT
only). The institutional review board of each clinical center approved the protocol of
the studies and all participants gave informed consent.
2.2. Depressive symptoms and clinical depression
The presence of depressive symptoms was assessed with the Beck Depression In-
ventory (BDI) [13] during hospitalization and again 3 months later. The BDI consists
of 21 items assessing the presence and severity of depressive symptoms. On each
item the score can range from 0 (not present) to 3 (very severe). Consequently, the
total BDI-score can range from 0 to 63. For the present analysis, BDI-scores at 3 months
post-MI were used to allow natural recovery of depressive symptoms after a major life
event.
Clinical depression was deﬁned as the presence of a post-MI depressive episode
according to ICD-10 criteria [5], obtained with the Composite International Diagnostic
Interview (CIDI) [14]. The interview was administered at 3 months post-MI by trained
psychologists. In DepreMI the CIDI was administered to all patients, in MIND-IT only to
those with a BDI-score≥10 at hospitalization and/or 3 months after the MI.
2.3. Covariates
Age, sex, smoking status and clinical characteristics including bodymass index, char-
acteristics of the index event, cardiac disease severity parameters, somatic comorbidity
and medication prescription at discharge were assessed during hospitalization for the
index-MI and obtained frommedical records. InMIND-IT left ventricular ejection fraction
(LVEF) was assessed by echocardiography and radionuclide ventriculography. In
DepreMI LVEF was assessed by wall motion score index, gated single photon emission
computed tomography, magnetic resonance imaging angiography, or clinical judgment
by the treating cardiologist and dichotomized at 40%. Because there was no uniform
procedure for assessing LVEF across the participating centers, for MIND-IT scores were
categorized into b30%, 30–45% and 45–60%, and ≥60%, and for DepreMI scores were
dichotomized at 40%. Therefore, in the present study, a dichotomized score for LVEF
was used, which was dichotomized at 40% for DepreMI and at 45% for MIND-IT. An
adapted version [15] of the Charlson Comorbidity Index [16] was calculated to assess
a cumulative burden of somatic comorbidity.
2.4. Cardiovascular events and mortality
Data concerning the date and cause of death were derived from Dutch Central
Bureau of Statistics by linkage to the municipal personal records database. Deaths
with ICD-10 codes I11 (hypertensive heart disease), I20–I25 (ischemic heart diseases),
I42–I50 (cardiomyopathy, conduction disorder, cardiac arrest, cardiac dysrhythmia,
heart failure) and R57.0 (cardiogenic shock) were considered as cardiac deaths. Data
concerning hospital readmissions were derived from the Dutch national registry of
hospital discharge diagnosis and were provided by the Dutch Central Bureau of Statis-
tics by linkage to the municipal personal records database. Hospital readmissions with
the following ICD-9 primary discharge diagnoses were considered cardiovascular
readmissions: ischemic heart disease (410, 411, 413, 414), cardiac arrhythmia
(427.1, 427.4, 427.5), heart failure (428, 398.91, 402.01, 402.11, 402.91, 404.01,404.03, 404.11, 404.13, 404.91, 404.93), cerebrovascular disease (433, 434, 435,
437.0, 437.1) and peripheral vascular disease (440, 443.9).
Data on potential endpoints were gathered up till 31 December 2007. The
follow-up period for mortality started at the index-MI and for cardiovascular related
readmissions at the depression assessment at 3 months post-MI. Patients who did
not have the outcome of interest until 31 December 2007 were censored on 31
December 2007 or the date of death as appropriate.
2.5. Statistical analyses
Missing data occurred in 0–6% of cases for the covariates, in 7% of cases for depres-
sive symptoms, in 15% of cases for clinical depression, and in 7% of cases for mortality,
and were imputed using multiple imputation [17]. Ten datasets were created where
missing values were replaced by imputed values estimated from observed variables,
including the outcomes. Using the outcomes for imputation of missing predictor values
has been shown to give more reliable results [18]. Patients with missing values on the
outcomes themselves were excluded from analyses, because including these adds
noise to the estimates [19,20]. All statistical analyses were performed on the imputed
data and Rubin's rules [17] were used to combine results from the individual datasets.
Demographical and clinical characteristics at baseline, BDI-scores and depression sta-
tus at 3 months post-MI were compared between patients with and without complete
data on outcome variables with logistic regression.
First, we compared baseline characteristics between patients with no elevated de-
pressive symptoms (BDIb10), patients with elevated depressive symptoms (BDI≥10),
but no clinical depression, and patients with elevated depressive symptoms and clini-
cal depression. For this purpose, multinomial logistic regression was used with pa-
tients with no elevated depressive symptoms as reference group. Second, with Cox
regression we examined risk of adverse outcomes associated with categorized
BDI-scores to evaluate a dose–response relationship. For this analysis, BDI-scores
were a priori categorized based on the BDI manual [21] into scores of 0 to 4, 5 to 9,
10 to 18 and ≥19. Third, we compared the risk of adverse outcomes between patients
with and without clinical depression. For this analysis, patients scoring b10 on the BDI
were categorized as having no clinical depression, because these patients were not ad-
ministered the CIDI in MIND-IT. By doing this, we misclassiﬁed approximately only 2%
of patients with BDI-scoresb10 as having no clinical depression [22]. The survival anal-
yses consisted of three models. Model 1 adjusted for age and sex as there were signif-
icant differences in the groups with respect to age and sex. Model 2 adjusted
additionally for LVEF and previous MI, because these are known to relate to depression
and cardiovascular prognosis in cardiac patients [23,24]. Model 3 additionally adjusted
for smoking and diabetes mellitus, because these are known to relate to depression as
well as cardiac disease [24–27]. Finally, we compared the prognostic impact of depres-
sive symptoms with that of clinical depression. For this purpose, we compared risk of
adverse outcomes between patients with no elevated depressive symptoms, patients
with elevated depressive symptoms, but no clinical depression, and patients with ele-
vated depressive symptoms and clinical depression, adjusting for the same covariates
as described above. In addition, we entered depressive symptoms and clinical depres-
sion simultaneously in the model to evaluate whether these predict cardiovascular
prognosis independent from each other. Because depressive symptoms were measured
as a continuous measure and clinical depression is a dichotomous measure, depressive
symptoms would have statistically more chance to remain independently associated
with adverse outcomes. To exclude this possibility, we used dichotomized BDI-scores
for depressive symptoms in this analysis. BDI-scores were dichotomized at 12, because
the proportion of those scoring >12 is similar to the proportion of patients with clin-
ical depression. Tolerance, variance inﬂation factor (VIF) and correlation coefﬁcients
were calculated to examine collinearity between depressive symptoms and clinical
depression.
For all survival analyses the proportional hazards assumption was tested by creat-
ing interaction terms of the predictors with the time-variable. All statistical analyses
were done with Stata 10. Signiﬁcance level was set at pb0.05, two-tailed.
3. Results
3.1. Sample
Of 2704 included MI patients, 32 died within the ﬁrst 3 months
after MI, and 238 patients had missing data on mortality and/or car-
diovascular readmissions. Analyses on mortality included 2493 pa-
tients and analyses on cardiovascular readmissions included 2434
patients (see Fig. 1). Patients with missing data on mortality were
more likely to have had a previous MI (21.5% versus 13.2%, pb0.01),
hypercholesterolemia (76.2% versus 67.5%, pb0.05), and cerebrovas-
cular disease (10.1% versus 5.5%, pb0.05), but did not differ from
those with mortality-data on other demographical and clinical char-
acteristics, depressive symptoms and clinical depression.
Of 2493 patients with complete data on mortality, 407 patients
died (16.3%) with a mean follow-up of 6.3 (1.9) years, of whom 156
MIND-IT: 4,779 
assessed for eligibility 
DepreMI: 1,166 
assessed for eligibility 
284 did not meet 
inclusion criteria 
354 no informed 
consent
1,403 did not meet 
inclusion criteria 
1,200 no informed 
consent
2,176 included in MIND-IT (of 
whom 331 participated in RCT) 
528 included in DepreMI 
2,704 patients participated (45% of eligible patients) 
2,493 (92%) included in analyses with outcome mortality 
32 died within 3 months post-
MI
179 no data on mortality and 
cardiovascular readmissions 
2,434 (90%) included in analyses with outcome 
cardiovascular readmissions 
59 no data on cardio-
vascular readmissions 
Fig. 1. Flow-chart.
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mortality was 16,783 person years. Of 2434 patients with complete
data on cardiovascular readmissions, 878 patients (36.1%) had atTable 1
Association of depression status at 3 months post-MI with demographical and clinical varia
BDIb10
(n=1618)
BDI≥10, n
depression
Age, mean (SD)b 61.0 (11.4) 63.4 (12.4)
Female (%)b 19.4 26.6
Smoker at hospitalization (%)b 47.2 47.4
Body mass index, mean (SD)b 26.7 (3.88) 26.6 (3.82)
Anterior site MI %b 32.4 36.5
Low LVEF (%)b,c 21.4 28.5
Killip Class≥2 (%)b 9.5 14.0
Previous MI (%)b 11.5 18.8
PTCA during hospitalization (n=2382) (%)d 35.5 32.7
CABG during hospitalization (n=2379) (%)d 4.9 4.8
Diabetes (%)b 10.6 16.1
Hypertension (%)b 31.7 35.2
Hypercholesterolemia (%)b 66.4 63.9
Peripheral vascular disease (n=2481) (%)d 6.2 9.9
Cerebrovascular disease (2478) (%)d 4.7 8.0
Family history CAD (%)b 43.4 40.6
Charlson Comorbidity Index (n=1934), median (IQR)d 0 (0–1) 1 (0–2)
Medication at discharge (%)d
Aspirin (n=2441) 85.9 81.9
Beta-blocker (n=2478) 84.9 80.9
Calcium antagonist (n=2441) 17.8 20.8
Diuretics (n=2478) 13.0 21.3
Ace-inhibitor (n=2478) 40.8 42.9
Statin (n=2478) 71.3 64.9
BDI score at 3 months post-MI mean (SD)b 3.7 (2.8) 11.1 (5.9)
Abbreviations: BDI: Beck Depression Inventory; CABG: coronary artery bypass graft; CAD: co
MI: myocardial infarction; PTCA: percutaneous transluminal coronary angioplasty; SD: stan
a Calculated with multinomial logistic regression.
b Mean, numbers and percentages represent the overall mean, the mean numbers and m
Rubin's rule.
c LVEFb40% in DepreMI and LVEFb45% in MIND-IT.
d Mean, numbers, and percentages are based on complete cases, because these variablesleast 1 cardiovascular readmission during a mean (SD) follow-up of
4.6 (2.8) years.3.2. Clinical depression, depressive symptoms and baseline characteristics
Depressive symptoms and clinical depression were associated
with several cardiac disease severity and risk factors (see Table 1).
Older age, previous MI and diabetes were associated with depressive
symptoms, but not with clinical depression. In contrast, younger age,
smoking, hypercholesterolemia and family history of coronary artery
disease were associated with clinical depression, but not with depres-
sive symptoms in the absence of clinical depression.3.3. Depressive symptoms and adverse outcomes
There was a dose response association between depressive
symptom severity and all-cause mortality with increasing risk for
patients with higher BDI scores after adjustment for age and sex
(see Table 2). For cardiac mortality, all patients scoring ≥10 on the
BDI were at increased risk. Additional adjustment for LVEF and pre-
vious MI attenuated the associations by 26–40%. Additional adjust-
ment for smoking and diabetes attenuated the associations with
another 2–5%.
For cardiovascular readmissions, all patients scoring ≥5 on the
BDI were at similar increased risk compared to those scoring below
5, after adjustment for age and sex. The association was attenuated
with 10–29% after additional adjusting for LVEF and previous MI,
and was no longer signiﬁcant for patients scoring ≥19 on the BDI.
Additional adjustment for smoking and diabetes attenuated the asso-
ciation with another 0 to 4%.bles at baseline in 2493 MI patients.
o clinical
(n=479)
BDI≥10 and clinical
depression (n=396)
p-Value 1
versus 2a
p-Value 1
versus 3a
p-Value 2
versus 3a
58.2 (11.5) b0.001 b0.001 b0.001
27.6 0.003 0.001 0.757
54.0 0.939 0.021 0.074
26.4 (4.23) 0.894 0.406 0.557
34.1 0.130 0.540 0.523
35.9 0.003 b0.001 0.033
15.6 0.009 0.001 0.536
13.4 b0.001 0.368 0.083
43.9 0.296 0.005 0.001
3.8 0.908 0.406 0.532
12.4 0.002 0.299 0.143
35.0 0.185 0.232 0.944
76.2 0.340 0.001 b0.001
10.9 0.013 0.003 0.670
5.3 0.022 0.698 0.197
48.5 0.322 0.082 0.027
0 (0–2) b0.001 0.001 0.507
85.0 0.051 0.690 0.257
82.3 0.046 0.253 0.610
19.9 0.153 0.393 0.767
15.5 b0.001 0.274 0.073
40.5 0.460 0.903 0.487
73.2 0.019 0.476 0.017
16.9 (15.7) b0.001 b0.001 b0.001
ronary artery disease; IQR: interquartile range; LVEF: left ventricular ejection fraction;
dard deviation.
ean percentages over the 10 imputed datasets. SDs are calculated taking into account
were not included in the imputation model.
Table 2
HR (95% CI) for adverse outcomes associated with BDI scores at 3 months post-MI.
BDI 5–9a BDI 10–18a BDI≥19a
All-cause mortality 133/759b 103/480b 43/153b
Model 1c 1.42 (1.10–1.82)⁎⁎ 2.01 (1.53–2.64)⁎⁎⁎ 3.20 (2.16–4.74)⁎⁎⁎
Model 2c 1.31 (1.02–1.68)⁎ 1.66 (1.25–2.20)⁎⁎⁎ 2.56 (1.71–3.82)⁎⁎⁎
Model 3c 1.29 (1.00–1.66)⁎ 1.62 (1.22–2.14)⁎⁎ 2.47 (1.64–3.70)⁎⁎⁎
Cardiac mortality 45/759b 53/480b 17/153b
Model 1c 1.54 (0.99–2.41) 3.31 (2.14–5.11)⁎⁎⁎ 3.97 (2.06–7.65)⁎⁎⁎
Model 2c 1.34 (0.86–2.10) 2.40 (1.53–3.76)⁎⁎⁎ 2.78 (1.43–5.41)⁎⁎
Model 3c 1.33 (0.85–2.08) 2.35 (1.50–3.69)⁎⁎⁎ 2.70 (1.38–5.27)⁎⁎
Cardiovascular
readmissions
294/737b 194/457b 57/146b
Model 1c 1.40 (1.19–1.62)⁎⁎⁎ 1.55 (1.29–1.86)⁎⁎⁎ 1.45 (1.08–1.95)⁎
Model 2c 1.36 (1.15–1.61)⁎⁎⁎ 1.45 (1.20–1.74)⁎⁎⁎ 1.32 (0.98–1.78)
Model 3c 1.36 (1.15–1.61)⁎⁎⁎ 1.43 (1.18–1.72)⁎⁎⁎ 1.30 (0.97–1.76)
Abbreviations: BDI: Beck Depression Inventory, CI: conﬁdence interval; HR: hazard
ratio.
a Reference group comprises patients with no depressive symptoms (BDI 0–4: 128/
1101 all-cause mortality, 41/1101 cardiac mortality, 333/1094 cardiac readmissions).
b Represents n with outcome/n with data on the outcome (mean number of patients
over the 10 imputed datasets).
c Model 1 adjusted for age and sex, model 2 adjusted for age, sex, LVEF and previous
MI, model 3 adjusted for age sex, LVEF, previous MI, diabetes and smoking.
⁎⁎ pb0.01 with Cox regression.
⁎⁎⁎ pb0.001 with Cox regression.
⁎ pb0.05 with Cox regression.
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Patients with clinical depression had higher mortality rates than
those with no clinical depression after adjustment for age and sex
(see Table 3). Additional adjustment for LVEF and previous MI atten-
uated these mortality rates with 26–40%, which were no longer sig-
niﬁcant for cardiac mortality. Additional adjustment for smoking
and diabetes attenuated the mortality rates with another 6–7%.
Clinical depression was not signiﬁcantly associated with the risk of
cardiovascular readmissions in any of the models.
3.5. Clinical depression versus depressive symptoms and adverse outcomes
Compared to patients with no elevated depressive symptoms, those
with elevated depressive symptoms had increased mortality-rates,
both in the absence and in the presence of clinical depression (see
Table 4). An increased risk of cardiovascular readmissions was only
found for patients with elevated depressive symptoms in the absence
of clinical depression. Among patients with elevated depressiveTable 3
HR (95% CI) for adverse outcomes associated with clinical depression the ﬁrst 3 months
post-MI.a.
All-cause mortality Cardiac mortality Cardiovascular
readmissions
71/396 vs 336/2,097b 27/396 vs 129/2,097b 138/362 vs 740/2,072b
Model 1c 1.72 (1.29–2.30)⁎⁎⁎ 1.67 (1.01–2.77)⁎ 1.13 (0.93–1.38)
Model 2c 1.53 (1.15–2.02)⁎⁎ 1.40 (0.86–2.28) 1.08 (0.88–1.32)
Model 3c 1.48 (1.12–1.96)⁎⁎ 1.36 (0.84–2.21) 1.08 (0.88–1.32)
Abbreviations: BDI: Beck Depression Inventory; CI: conﬁdence interval; HR: hazard
ratio; MI: myocardial infarction.
a Reference group comprises patients with no clinical depression or BDI-scores b10.
b Numbers represent the mean number of patients over the 10 imputed datasets.
c Model 1 adjusted for age and sex, model 2 adjusted for age, sex, LVEF and previous
MI, model 3 adjusted for age, sex, LVEF, previous MI, diabetes and smoking.
⁎⁎⁎ pb0.001 with Cox regression analysis.
⁎ pb0.05 with Cox regression analysis.
⁎⁎ pb0.01with Cox regression analysis.symptoms, there was no difference in risk of all three outcomes be-
tween those with and those without clinical depression.
Adjusting for the continuous BDI-score attenuated the age-and
sex-adjusted risk of all-cause mortality associated with clinical de-
pression with 53%, and of cardiac mortality with 72%, rendering
both to non-signiﬁcant (see Table 5). This was 60% and 82% respec-
tively when adjusting for the dichotomized BDI-score. Clinical de-
pression was not associated with cardiovascular readmissions in any
of the models. Patients scoring >12 on the BDI were at increased
risk of all three outcomes after adjustment for age and sex. Additional
adjustment for clinical depression attenuated the HR's for all-cause
and cardiac mortality with 20% and 8% respectively, and increased
the HR for cardiovascular readmissions with 17%. There was no
multicollinearity between clinical depression and continuous or di-
chotomized BDI scores (variance inﬂating factors: 1.36 and 1.25,
tolerance: 0.73 and 0.80, correlation coefﬁcient r: 0.46 and 0.45).
4. Discussion
In 2493 MI patients, both elevated depressive symptoms and clin-
ical depression were associated with cardiac morbidity and mortality
after an MI. Cardiac disease severity and risk factors explained one
third to half of this increased risk, rendering some associations to-
wards non-signiﬁcance. Interestingly, the increased risk associated
with clinical depression could be explained by higher levels of de-
pressive symptoms in patients with clinical depression, whereas the
increased risk associated with depressive symptoms could not be
explained by clinical depression.
Strengths of the present study include the large sample size in
which both self-reported depressive symptoms and clinical depres-
sion were evaluated. Furthermore, the use of a long follow-up period
for the outcomes resulted in a relatively large number of patients
with the outcome, giving enough power to detect effects and enabling
multivariate analyses without introducing bias due to overﬁtting. The
fact that results are similar when ‘hard’ (mortality) and ‘soft’ (cardio-
vascular readmissions) endpoints were evaluated, supports the ro-
bustness of the present ﬁndings. Another strength is that we
evaluated depression 3 months post-MI, in contrast to many other
studies that evaluated depression during hospital admission. Evaluat-
ing depression 3 months post-MI, rather than during hospital admis-
sion, allows natural recovery of depressive symptoms after a stressful
life event and enables the identiﬁcation of post-MI clinical depression
for which symptoms have to be present during a period of at least
2 weeks. The present study has also some limitations. First, no infor-
mation on health care utilization during the follow-up period is pres-
ent. Perhaps patients with clinical depression were more likely
identiﬁed by care providers or received more aggressive antidepres-
sant or cardiac care during follow-up. Second, combining data from
two studies with different design and exclusion criteria may be prob-
lematic. Patients with clinical depression in MIND-IT were enrolled in
a clinical trial on antidepressant treatment [11,12], whereas DepreMI
was an observational cohort study. However, MIND-IT-patients in the
intervention arm had no better long-term outcomes than patients in
the care-as-usual arm who were not informed about their depression
status (Zuidersma et al., submitted). Therefore, it is unlikely that the
fact that MIND-IT was an RCT, whereas DepreMI was not, has biased
the results of the present analyses. Furthermore, for MIND-IT, but
not DepreMI, receiving psychiatric treatment for depression was an
exclusion criterion. However, the two studies were highly compara-
ble with regard to severity of clinical depression and its association
with adverse outcomes (data not shown). Hence, it is unlikely that
the exclusion of these patients in MIND-IT has biased the results.
Third, patients with missing data on mortality (6.6% of the sample)
had a somewhat worse cardiovascular proﬁle than those with data
onmortality, whichmay have introduced selection bias. However, be-
cause there were no differences between those with missing data on
Table 4
HR (95% CI) for adverse outcomes associated with depression status at 3 months post-MI.
BDI≥10, no clinical
depression vs BDIb10
BDI≥10 and clinical
depression vs BDIb10
BDI≥10 and clinical
depression vs BDI≥10,
no clinical depression
All-cause mortality 120/479 vs 216/1,618a 71/396 vs 216/1,618a 71/396 vs 120/479a
Model 1b 1.71 (1.35–2.17)⁎⁎⁎ 2.02 (1.50–2.72)⁎⁎⁎ 1.19 (0.85–1.67)
Model 2b 1.49 (1.17–1.89)⁎⁎ 1.73 (1.29–2.32)⁎⁎ 1.15 (0.83–1.60)
Model 3b 1.46 (1.15–1.85)⁎⁎ 1.67 (1.25–2.24)⁎⁎ 1.13 (0.82–1.57)
Cardiac mortality 57/479 vs 72/1,618a 27/396 vs 72/1,618a 27/396 vs 57/479a
Model 1b 2.48 (1.72–3.57)⁎⁎⁎ 2.26 (1.33–3.83)⁎⁎ 0.96 (0.55–1.67)
Model 2b 1.95 (1.34–2.84)⁎⁎⁎ 1.78 (1.06–2.99)⁎ 0.92 (0.53–1.57)
Model 3b 1.92 (1.32–2.79)⁎⁎ 1.73 (1.03–2.91)⁎ 0.89 (0.52–1.53)
Cardiovascular readmissions 198/468 vs 542/1,604a 138/362 vs 542/1,604a 138/362 vs 198/468a
Model 1b 1.34 (1.12–1.60)⁎⁎ 1.21 (0.99–1.49) 0.91 (0.71–1.18)
Model 2b 1.27 (1.06–1.52)⁎ 1.14 (0.93–1.40) 0.90 (0.69–1.16)
Model 3b 1.24 (1.04–1.49)⁎ 1.14 (0.93–1.39) 0.91 (0.70–1.19)
Abbreviations: BDI: Beck Depression Inventory; CI: Conﬁdence Interval; HR: Hazard Ratio; NA: not applicable.
a Numbers represent the mean number of patients over the 10 imputed datasets.
b Model 1 adjusted for age and sex, model 2 adjusted for age, sex, LVEF and previous MI, model 3 adjusted for age, sex, LVEF, previous MI, diabetes and smoking.
⁎⁎⁎ pb0.001 with Cox regression analysis.
⁎⁎ pb0.01 with Cox regression analysis.
⁎ pb0.05 with Cox regression analysis.
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and clinical depression, it is unlikely that this selection bias has affect-
ed the results. Finally, MIND-IT patients scoring below 10 on the BDI
were not assessed for clinical depression. Therefore, we may have
missed some cases of clinical depression. However, since the nega-
tive predictive value of BDI-scores≤10 is about 2% [22], it is safe
to assume that that this would not have substantially affected the
results.
In contrast to our ﬁndings, a recent meta-analysis [2] reported
higher odds ratio's for all-cause mortality and cardiovascular
readmissions associated with clinical depression than with self-
reported depressive symptoms in MI patients. However, this meta-
analysis compared the prognostic impact of self-reported depressive
symptoms with that of clinical depression using different study
samples. Only few studies compared the prognostic impact of self-
reported depressive symptoms and clinical depression in the same sam-
ple, and found inconsistent results [6–9]. The present studywas theﬁrst
to evaluate whether self-reported depressive symptoms predict ad-
verse outcomes independent from clinical depression and vice versa.
Findings of the present study suggest that the BDI is a more accu-
rate tool for predicting adverse outcomes after MI than the CIDI,
whichmay be due to the overlap between BDI and somatic health sta-
tus. To obtain a diagnosis of clinical depression, the individual depres-
sive symptoms may not be the result of a physiological problem,
whereas this restriction does not apply for the BDI. Furthermore,
the BDI contains several somatic-related symptoms, which are notTable 5
Independent prognostic impact of clinical depression and BDI-scores.
All-cause mortality
Clinical depression 71/396 vs 336/2,097a
Adjusted for:
Age, sex 1.72 (1.29–2.30)⁎⁎⁎
Age, sex, BDI (cont) 1.34 (0.89–2.03)
Age, sex, BDI>12 1.29 (0.92–1.80)
BDI>12 97/401 vs 310/2,092a
Adjusted for:
Age, sex 1.96 (1.54–2.49)⁎⁎⁎
Age, sex, depression diagnosis 1.77 (1.34–2.35)⁎⁎⁎
Abbreviations: BDI: Beck Depression Inventory; CI: conﬁdence interval; CIDI: Composite In
a Numbers represent the mean number of patients over the 10 imputed datasets.
⁎⁎⁎ pb0.001 with Cox regression analysis.
⁎ pb0.05 with Cox regression analysis.included in the CIDI (i.e. irritability, work difﬁculties, and worries
about health). EvenMI patients with relatively mild depressive symp-
toms were at increased risk, which has also been found by others
[28,29]. Therefore, also MI patients with only mild depressive symp-
toms need to be monitored carefully.
One third to half of the association between depressive symptoms
and adverse outcomes was explained by cardiac disease severity and
risk factors, conﬁrming ﬁndings from previous studies, that suggest
that disease severity plays a major role in the association between de-
pression and cardiovascular prognosis [1,30,31]. Perhaps even more
of the association can be explained by other somatic health parame-
ters or health behaviors. Beyond the parameters that were adjusted
for in the present study, other parameters of somatic health status,
such as the Charlson Comorbidity Index, were strongly associated
with depressive symptoms. Furthermore, in other studies, physical
inactivity has been found to explain a fourth to a third of the poor car-
diac outcomes associated with depressive symptoms [7,32]. Unfortu-
nately, even though we used a very large sample of MI patients, the
sample was still too small to adjust for more covariates without intro-
ducing bias [33].
The ﬁnding that depressive symptoms rather than clinical depres-
sion drive the increased risk of adverse outcomes does not mean that
clinical depression in MI patients can be ignored. Clinical depression
is a burdensome condition that in itself deserves attention, and
some MI patients may have a serious and life-threatening depression
and should be provided with appropriate treatment or referral.Cardiac mortality Cardiovascular readmissions
27/396 vs 129/2,097a 138/362 vs 740/2,072a
1.67 (1.01–2.77)⁎ 1.13 (0.93–1.38)
1.19 (0.65–2.18) 0.96 (0.74–1.25)
1.12 (0.64–1.96) 0.91 (0.72–1.16)
42/401 vs 115/2,092a 167/380 vs 711/2,054a
2.26 (1.55–3.29)⁎⁎⁎ 1.42 (1.19–1.69)⁎⁎⁎
2.16 (1.42–3.28)⁎⁎⁎ 1.49 (1.20–1.84)⁎⁎⁎
ternational Diagnostic Interview.
2780 M. Zuidersma et al. / International Journal of Cardiology 167 (2013) 2775–2780Clinicians and researchers designing future trials should take into
account potential differences in cardiovascular risk associated with
self-reported depressive symptoms and clinical depression. Future
studies should take into account and evaluate the possibility that
self-reported depressive symptoms and clinical depression have a
partly different etiology in MI patients. Clinicians should monitor
closely the course of the cardiac disease severity in MI patients show-
ing depressive symptoms. The present study suggests that it might
beneﬁt MI patients when they are evaluated with the BDI at 3 months
after their MI. However, there is no empirical evidence yet that this
would result in better outcomes, in the absence of optimal treatment
strategies [22]. Perhaps future studies should evaluate the effective-
ness of treatment strategies, such as cardiac rehabilitation and physi-
cal exercise [34–37], for patients with elevated depressive symptoms
during the ﬁrst months following MI.
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